Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our Websites |
     
  3. Global Business Webistes |
     
  4. Contact Us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce font size Increase font size  
 
 

About us

Contact us

Sanofi House,
CTS No.117-B, L&T Business Park,
Saki Vihar Road, Powai,
Mumbai 400072

Tel no. (022) 28032000
Fax no.(022) 28032846

For redressal of investor grievances,

please write to
or contact Mr. Girish Tekchandani,
Company Secretary &
Compliance Officer

E-Mail ID :
igrc.sil@sanofi.com

Tel.: (91-22) 28032000
Fax: (91-22) 28032846

Content :

A world-class pharmaceutical manufacturer

Sanofi India Limited was incorporated in May 1956 under the name Hoechst Fedco Pharma Private Limited. Over the years, its name was changed to Hoechst Pharmaceuticals Private Limited, Hoechst India Limited, Hoechst Marion Roussel Limited and Aventis Pharma Limited.

 

Sanofi, one of the world's leading pharmaceutical companies, and its 100% subsidiary, Hoechst GmbH, are the major shareholders of Sanofi India Limited and together hold 60.4% of its paid-up share capital.

The shares of Sanofi India Limited are quoted on the Bombay Stock Exchange (Security Code: 500674) and the National Stock Exchange (Security Code: Sanofi).

SANOFI INDIA LIMITED

Updated April 21, 2016

Module :

Corporate information

Corporate information

 

Medical Information / Pharmacovigilance

A key activity of Sanofi is to provide updated medical information on its products, to healthcare professionals, which is in compliance with Indian regulations. All consumers or patients are advised to contact their doctor or healthcare professional for advice on medicines or any health matters.
For medical information, contact:
medinfo.india@sanofi.com / Tel no. (022) 28032000 , Extension 2063

Sanofi also ensures continuous monitoring and management of the safety profile of all its products through its drug safety data collection worldwide, as pharmacovigilance remains a key activity in the assessment of the therapeutic value of products.
For Reporting adverse events, contact:
PV.india@sanofi.com / Tel no. (022) 28032000 , Extension 2055